Aclaris Therapeutics, Inc. Gains 220.24%

Tue, Jan 19, 2021 at 05:30 PM
Aclaris Therapeutics, Inc. Gains 220.24%

Aclaris Therapeutics, Inc. (ACRS:NASDAQ) soared at $18.83, a gain of 220.2%. On Fri 15 Jan 21, ACRS:NASDAQ touched a New 2-Week Intraday Low of $5.82. The stock appeared on our News Catalysts scanner on Tue 19 Jan 21 at 04:09 PM in the 'PUBLIC OFFERING' category. From Mon 04 Jan 21, the stock recorded 44.44% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Aclaris Therapeutics, Inc. (ACRS:NASDAQ)

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.